MABTHERA

Solution for injection, 1600mg/13.4ml
RxActive license

Active substance (INN)

rituximab

Pharmaceutical form

Pharmaceutical formSolution for injection
Strength1600mg/13.4ml
PackagingUkupno 1 bočica staklena sa 13.4ml rastvora za injekciju u kartonskoj kutiji
ManufacturerF. Hoffmann-La Roche AG, Switzerland
Therapeutic groupAntineoplastic and immunomodulating agents (L01FA01)
Marketing authorization holder"Hoffmann-La Roche LTD" D.S.D. Podgorica
Authorization dateJuly 23, 2025

Analogs in Montenegro

7

Other medicines with the same active substance

MABTHERARx
Solution for injection, 1400mg/11.7mlF. Hoffmann-La Roche AG
MABTHERARx
Concentrate for solution for infusion, 500mg/50mlF.Hoffmann-La Roche Ltd.
MABTHERARx
Concentrate for solution for infusion, 100mg/10mlF.Hoffmann-La Roche Ltd.
RIXATHONRx
Concentrate for solution for infusion, 100mg/10mlSandoz GmbH Schaftenau
RIXATHONRx
Concentrate for solution for infusion, 500mg/50mlSandoz GmbH Schaftenau
RUXIENCERx
Concentrate for solution for infusion, 100mgPfizer Manufacturing Belgium NV
RUXIENCERx
Concentrate for solution for infusion, 500mgPfizer Manufacturing Belgium NV
Source: CInMED register